Cytiva is a privately owned company headquartered in the US. Founded in 1968, the company provides life sciences brands such as ÄKTA, Amersham, HyClone, MabSelect, and Whatman.
On June 23, 2026, Cytiva announced a webinar where Charles River will present comparative data on its Sefia™ platform against an all-in-one standard solution for automated CAR T manufacturing, aiming to provide objective data for platform selection. Previously, on June 22, 2026, Cytiva detailed its HyClone™ boost expression supplement, a two-part chemically defined, animal component-free formulation engineered to enhance transient adeno-associated virus (AAV) vector production in HEK 293 cells, including its ELEVECTA™ cell line. Earlier on the same day, CellFiber announced it will co-host a Next-Generation Stem Cell Manufacturing and Commercialization Strategy Workshop with Cytiva on July 15, 2026, at the Cytiva APAC Fast Trak™ Center in Songdo, Incheon, a program designed for researchers and developers advancing mesenchymal stem cell (MSC) and induced pluripotent stem cell (iPSC) therapies.
Subscribe for full access to Cytiva's products in full detail
Subscribe for full access to Cytiva's revenue in full detail
Subscribe for full access to Cytiva's products in full detail 
